Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alcami Expands Fill/Finish Manufacturing Capacity | Contract Pharma
Breaking News

Alcami Expands Fill/Finish Manufacturing Capacity

Adds new, fully automated GMP sterile filling line that offers the flexibility to fill liquid and freeze-dried vials under isolator technology.

Alcami Corp., a CDMO, has expanded its sterile fill/finish manufacturing capacity with the addition of a new sterile fill/finish line with isolator and two lyophilizers at its existing Charleston, SC manufacturing campus. The new state-of-the-art, fully automated GMP sterile filling line offers the flexibility to fill liquid and freeze-dried vials under isolator technology to minimize the potential for contamination, providing the capacity and scalability for clinical and commercial needs. The line is fully integrated with the company’s network of formulation development, packaging / labeling, lab services and pharma storage and services facilities.
 
The expansion aims to meet growing industry demands for onshore sterile fill/finish capabilities amidst supply constraints, industry consolidation and tightening capacity as the pipeline of biologics and specialty therapeutics continues to grow.
 
“In a tight market, capacity is at a premium and conditions favor those with immediate capabilities. As Alcami continues to align with the future of pharma and biotech, we’re meeting increased demand with this new sterile fill/finish manufacturing line on our Charleston campus,” said Bill Humphries, CEO of Alcami. “Because Alcami offers integrated services through every stage of the development lifecycle, we can help clients mitigate supply chain risks by providing onshore, streamlined and cost-efficient solutions. We’re committed to offering the latest manufacturing, analytical and storage capabilities and plan continued expansion of our manufacturing capacity to help bring our clients’ innovative therapeutics to patients.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters